ClinicalTrials.gg
Sign In

Liver Diseases clinical trials

The registry lists 824 studies for Liver Diseases across more than 10 countries. 152 are recruiting or about to start. 313 of them are mainly about Liver Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 41 narrower conditions too, such as Carcinoma, Hepatocellular: 13,788 studies, 2,859 open.

ClinicalTrials.gov finds 15,196 studies for Liver Diseases. How that becomes 824 here

This page counts the studies the registry files under Liver Diseases, and those it files under no condition that list Liver Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 15,196Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −12,335Filed under a narrower condition, counted on its own pageCarcinoma, Hepatocellular 3,327 · Hepatitis C 1,607 · Non-alcoholic Fatty Liver Disease 1,490 · Liver Cirrhosis 927 · Hepatitis B 810 · Liver Neoplasms 733 · 35 more
  3. −326List Liver Diseases as a condition, but the registry did not file them under itMost often written as “Chronic Liver Disease” (72), “Metabolic Dysfunction-associated Steatotic Liver Disease” (42), and “MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease” (18). The registry filed 145 of them under no condition at all, and the others under other conditions only, most often Fibrosis (37) and Diabetes Mellitus, Type 2 (22).
  4. −1,711Match it another way165 name it in the title, 21 in a keyword, and 1,525 by a synonym or other text the search reads.
  5. 824The count on this page

Get an email when these change. Save the Liver Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
439
Status unknown
106
Recruiting
103
Terminated
55
Not yet recruiting
37
Active, not recruiting
35

Phase

Phase 2
128
Phase 1
119
Phase 3
57
Phase 4
56
Early Phase 1
1

Where

United States
367
United Kingdom
72
France
69
China
64
Germany
54
Spain
51

Who runs them

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (21) · Gilead Sciences (15) · National Institute of Allergy and Infectious Diseases (NIAID) (10) · Mirum Pharmaceuticals, Inc. (9) · University of Michigan (9) · Institute of Liver and Biliary Sciences, India (9) · Assistance Publique - Hôpitaux de Paris (9) · Assiut University (7)

What is being tested here

Drugs under test in Liver Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pegozafermin224
Hepatitis B Virus Antisense Oligonucleotide AHB-137202
Apixaban202
Lenvatinib202
Maralixibat125
Acetylcysteine105
Rifaximin104
Everolimus113
Bepirovirsen102
Bupropion101

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 4 open · Immune checkpoint inhibitors 2 open · mTOR inhibitors 1 open · Angiogenesis inhibitors 3 · Antimetabolites 3

Coming up

10phase 3 studies under way
49studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 103 Liver Diseases studies recruiting now, 51 (50%) set no upper age limit and 30 (29%) stop at 75 or younger. 19 (18%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 19 (18%) take healthy volunteers.

Recruiting studies that take each age, of 103
AgeWomenMen
1014 (14%)14 (14%)
1898 (95%)98 (95%)
3095 (92%)95 (92%)
4096 (93%)96 (93%)
5096 (93%)96 (93%)
6593 (90%)93 (90%)
7583 (81%)83 (81%)
8560 (58%)60 (58%)

Across all 824 studies, recruiting or not: 37% stop at 75 or younger and 18% at 65; 16% take children; 1% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Liver Diseases studies take

Of 53 phase 1 interventional studies under Liver Diseases, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 114 mo5–21 · 53 studies13 mo5–20 · 48 studies—
Phase 1/249 mo33–85 · 13 studies——
Phase 236 mo18–49 · 41 studies——
Phase 354 mo37–70 · 19 studies——
Phase 440 mo21–57 · 26 studies——
Interventional, no phase24 mo12–47 · 135 studies—25 mo12–50 · 122 studies
Observational47 mo22–120 · 117 studies—48 mo29–124 · 103 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting3

Results posted1

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 824. Browse all 824 → or search them.